GO
Loading...

Science

More

  • Roche's blockbuster pharma deal     Monday, 25 Aug 2014 | 3:47 PM ET

    CNBC's Meg Tirrell breaks down the mega deal between Swiss pharmaceutical firm Roche and InterMune for $8.3 billion.

  • Roche CEO: InterMune perfect strategic fit     Monday, 25 Aug 2014 | 11:18 AM ET

    CNBC's Meg Tirrell speaks to Roche CEO Severin Schwan, and InterMune CEO Daniel Welch, about Roche's $8.3 billion acquisition of InterMune and the opportunity for the drug Esbriet in the U.S.

  • GPS discovers the West is so dry, it's rising Friday, 22 Aug 2014 | 4:59 PM ET
    California mountains dry lake

    California's mountains have risen more than half an inch, thanks to the absence of water to weigh them down, a study found. NBC News reports.

  • ALS raises over $13 million since July 29th     Monday, 18 Aug 2014 | 6:25 AM ET

    CNBC's Andrew Ross Sorkin looks back on some of the best ice bucket challenge videos from last week, including from Bill Gates, saying the campaign has now hit China.

  • SeaWorld plans bigger killer whale environments Friday, 15 Aug 2014 | 9:18 AM ET

    NEW YORK— After more than a year of public criticism of its treatment of killer whales, SeaWorld said Friday that it will build new, larger environments at its theme parks and will fund additional research on the animals along with programs to protect ocean health and whales in the wild.

  • ALS stunned by millions of dollars     Friday, 15 Aug 2014 | 7:36 AM ET
    Guests on "The Tonight Show Starring Jimmy Fallon" participate in the 'Ice Bucket Challenge' on August 12, 2014.

    Lance Slaughter from the ALS Association, discusses the phenomenon spreading across social media to dump a bucket of ice over your head to raise awareness for ALS.

  • What is ALS?     Friday, 15 Aug 2014 | 7:32 AM ET

    CNBC's Meg Tirrell explains what ALS, or Lou Gehrig's disease is, and what is known about treating the disease.

  • 10 economies hit hard by climate change Thursday, 14 Aug 2014 | 4:41 AM ET

    CNBC looks at which countries may be worst hit, both environmentally and economically, by climate change.

  • VOTE: Are we ready for genetically modified babies? Monday, 11 Aug 2014 | 2:44 PM ET

    Is the world ready for genetically modified babies? Here's how close we really are, explains Jessica Cussins of the Center for Genetics and Society.

  • Therapies in early development for Ebola     Monday, 11 Aug 2014 | 1:07 PM ET

    CNBC's Meg Tirrell reports the World Health Organization has convened a panel of medical ethicists to discuss the potential treatment for Ebola patients with experimental therapies.

  • Changing compassionate use     Friday, 8 Aug 2014 | 3:12 PM ET

    With the World Health Organization declaring Ebola an international public health emergency, CNBC's Meg Tirrell discusses the use of experimental drugs as a last resort to treat patients stricken with Ebola, cancer and other disease.

  • Tracking Ebola     Friday, 8 Aug 2014 | 11:38 AM ET

    The World Health Organization has declared the Ebola virus an international public health emergency. CNBC's Meg Tirrell reports the details.

  • Tekmira's Ebola program gets good news     Thursday, 7 Aug 2014 | 4:54 PM ET

    The FDA has ruled to allow the potential use of drug maker Tekmira's Ebola drug on patients, reports CNBC's Meg Tirrell.

  • Is US prepared for a pandemic?     Thursday, 7 Aug 2014 | 1:21 PM ET

    Irwin Redlener author of "Americans at Risk," weighs in on the Ebola outbreak and discusses if the U.S. is adequately prepared to handle an epidemic.

  • President Obama discusses the Ebola outbreak, and the unproven and untested drug in the U.S. that appears to be helping infected American patients.

  • Trouble with experimental treatments     Wednesday, 6 Aug 2014 | 2:25 PM ET

    Tom Geisbert, University of Texas Medical Branch, shares concerns for experimental treatments for the Ebola virus.

  • Ebola & the business of vaccines     Tuesday, 5 Aug 2014 | 3:18 PM ET

    Darria Long Gillespie, Emory University Hospital emergency physician, discusses at what point companies will begin to invest in vaccines to treat rare diseases like Ebola.

  • Global response to Ebola     Tuesday, 5 Aug 2014 | 3:16 PM ET

    CNBC's Eamon Javers reports two American aid workers infected with Ebola are being treated at Emory Hospital in Atlanta today and the U.S. Centers for Disease Control and Prevention is sending 50 additional experts to Africa.

  • Enormous hype about Ebola: Doctor     Tuesday, 5 Aug 2014 | 2:17 PM ET
    Members of Doctors Without Borders (MSF) put on protective gear at the isolation ward of the Donka Hospital, on July 23, 2014 in Conakry.

    Breaking down the realistic threat of Ebola, and whether hospitals are prepared, with Dr. Peter Hotez, M.D. of Baylor College of Medicine.

  • Risk & compassionate use drug requests     Tuesday, 5 Aug 2014 | 1:30 PM ET

    Compassionate use is a way for companies to provide experimental drugs outside of clinical trials for patients with no other options. CNBC's Meg Tirrell reports on the risks for patients and drug makers.